[New therapy with blood components in vascular diseases of fundus oculi].
The concentrations of the hemostatic system components (plasminogen, fibronectin, alpha 2-macroglobulin, alpha 1 proteinase inhibitor, and antithrombin III) were measured in activated and intact plasma. Activated autoplasma was used in the treatment of patients with central chorioretinal dystrophy. After therapy vision acuity increased in 74.3% (52 eyes) and did not change in 25.7% (18 eyes) of cases.
Mykha
A I
AI
Department of Pathophysiology and Biochemistry, Moscow NII of Eye Diseases.
D000368:Aged; D000369:Aged, 80 and over; D016913:Blood Component Transfusion; D001804:Blood Transfusion, Autologous; D015862:Choroid Diseases / Q000097:blood / Q000628:therapy*; D003228:Conjunctiva; D005260:Female; D005654:Fundus Oculi; D006487:Hemostasis; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D010952:Plasma Substitutes / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D012164:Retinal Diseases / Q000097:blood / Q000628:therapy*; D016896:Treatment Outcome; D014792:Visual Acuity
D010952:Plasma Substitutes